Kiran Mazumdar-Shaw Explains Biocon's Q2 Performance

  • 3:41
  • Published On: October 21, 2015
Cinema View
Embed
Kiran Mazumdar-Shaw, chairman and managing director at Biocon, said its net profit rose over 200 per cent to Rs 306 crore for the July-September quarter supported by one-time gains from Syngene's share sale.

Related Videos

"Historic Moment": Kiran Mazumdar-Shaw On Women's Quota Bill
September 19, 2023 4:19
"Much Needed, Was Long Overdue": Entrepreneur Kiran Mazumdar Shaw
September 18, 2023 1:38
World Health Day Special: Kiran Mazumdar Shaw On How Can India Achieve Health For All
April 06, 2023 8:38
Kiran Mazumdar Shaw's World Health Day Message
April 06, 2023 0:34
"I Don't Worry": Kiran Shaw Assures Bright Future For 'Agniveers'
June 20, 2022 2:36
"Agniveers Will Have Distinct Advantage In Job Market": Biocon's Kiran Shaw
June 20, 2022 5:42
Kiran Mazumdar Shaw On Budget Disappointments
February 01, 2022 8:16
"Shouldn't Overreact To Delays In Covaxin Approval": Biocon's Kiran Shaw To NDTV
November 03, 2021 25:09
Equitable Access To Vaccines Important: Kiran Mazumdar Shaw
May 06, 2021 12:20
Covid-19 Vaccine Pricing: Private Risk Or Public Funding?
April 30, 2021 4:20
'One Nation, Many Prices' Policy Sparks Controversy
April 30, 2021 2:50
Outrage Grows Over Vaccine Rate Cards
April 30, 2021 3:17
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination